CN111329057A - Haematococcus pluvialis astaxanthin health food and preparation method thereof - Google Patents
Haematococcus pluvialis astaxanthin health food and preparation method thereof Download PDFInfo
- Publication number
- CN111329057A CN111329057A CN201811551731.XA CN201811551731A CN111329057A CN 111329057 A CN111329057 A CN 111329057A CN 201811551731 A CN201811551731 A CN 201811551731A CN 111329057 A CN111329057 A CN 111329057A
- Authority
- CN
- China
- Prior art keywords
- haematococcus pluvialis
- astaxanthin
- extract
- fine powder
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000168517 Haematococcus lacustris Species 0.000 title claims abstract description 44
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 31
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 30
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 30
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 30
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 30
- 235000013402 health food Nutrition 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 22
- 235000010254 Jasminum officinale Nutrition 0.000 claims abstract description 13
- 241000208278 Hyoscyamus Species 0.000 claims abstract description 9
- 235000010580 Psophocarpus tetragonolobus Nutrition 0.000 claims abstract description 9
- 241000046198 Triteleia hyacinthina Species 0.000 claims abstract description 9
- 229940069765 bean extract Drugs 0.000 claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 12
- 238000001694 spray drying Methods 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 240000005385 Jasminum sambac Species 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 22
- 239000007901 soft capsule Substances 0.000 abstract description 13
- 241000207840 Jasminum Species 0.000 abstract description 12
- 230000003078 antioxidant effect Effects 0.000 abstract description 9
- 239000004359 castor oil Substances 0.000 abstract description 9
- 235000019438 castor oil Nutrition 0.000 abstract description 9
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 abstract description 9
- 238000000034 method Methods 0.000 abstract description 8
- 235000013305 food Nutrition 0.000 abstract description 7
- 239000003963 antioxidant agent Substances 0.000 abstract description 6
- 235000006708 antioxidants Nutrition 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 5
- 239000002775 capsule Substances 0.000 abstract description 4
- 230000000295 complement effect Effects 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 230000000087 stabilizing effect Effects 0.000 abstract description 2
- 108010010803 Gelatin Proteins 0.000 description 11
- 229920000159 gelatin Polymers 0.000 description 11
- 239000008273 gelatin Substances 0.000 description 11
- 235000019322 gelatine Nutrition 0.000 description 11
- 235000011852 gelatine desserts Nutrition 0.000 description 11
- 239000000463 material Substances 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 235000013871 bee wax Nutrition 0.000 description 6
- 239000012166 beeswax Substances 0.000 description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000000787 lecithin Substances 0.000 description 5
- 235000010445 lecithin Nutrition 0.000 description 5
- 229940067606 lecithin Drugs 0.000 description 5
- 238000007873 sieving Methods 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- 238000001816 cooling Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 210000000582 semen Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000195493 Cryptophyta Species 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 241000628997 Flos Species 0.000 description 2
- 240000008669 Hedera helix Species 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 240000000528 Ricinus communis Species 0.000 description 2
- 235000004443 Ricinus communis Nutrition 0.000 description 2
- 208000003464 asthenopia Diseases 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012856 weighed raw material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a haematococcus pluvialis astaxanthin health food and a preparation method thereof, the formula of the invention takes astaxanthin as a main raw material, and is supplemented with high-quality raw materials which are famous and precious in China and are used as both food and medicines: white hyacinth bean extract, henbane seed extract and jasmine flower extract; the formula is reasonable, the advantages are complementary, and the antioxidant function of the astaxanthin is further enhanced; the method for extracting the haematococcus pluvialis fine powder is adopted, so that the main effective component astaxanthin in the haematococcus pluvialis fine powder is reserved to a greater degree. Meanwhile, according to the preparation method of the capsule provided by the invention, the jasmine flower extract, the castor oil and the like are added, so that the jasmine flower extract, the castor oil and the like have an antioxidant activity function, and the capsule plays a role in preventing astaxanthin from being oxidized and stabilizing the soft capsule in the formula.
Description
Technical Field
The invention belongs to the technical field of development of modern health-care food, and particularly relates to haematococcus pluvialis astaxanthin health-care food and a preparation method thereof.
Technical Field
Astaxanthin is a raw material of natural health food which is consistently recognized in the health food markets at home and abroad and has a plurality of important physiological and biological functions of antioxidant activity, anti-tumor, immunity enhancement and the like. The oxidation resistance of the vitamin E is 1000 times of that of vitamin E and 10 times of that of carotene. Astaxanthin is mainly present in natural raw materials of algae, haematococcus pluvialis, and is a well-known strong antioxidant material in algae. Astaxanthin also has relieving effect on eye diseases, cardiovascular diseases and rheumatoid arthritis; the astaxanthin has obvious improvement effect on visual fatigue of video display terminal operators, is helpful for eliminating body discomfort caused by time difference, and has more obvious effect than the commonly used melatonin. Therefore, the astaxanthin has important nutritive value and health care function. However, astaxanthin is not synthesized by the human body like vitamins, and can only be taken from food, so that the astaxanthin active ingredient contained in the health food is extracted from Haematococcus pluvialis in the formula.
Astaxanthin, namely 3, 3, -dihydroxy-4, 4, -diketo- β, -carotene, molecular formula C40H52O4, molecular weight 596.86, is pink, is a fat-soluble carotenoid, has many important physiological and biological functions such as oxidation resistance, tumor resistance and immunity enhancement, has the oxidation resistance of 500-1000 times that of vitamin E, 10 times that of carotene, is a strong antioxidant recognized by aquatic algae, can inhibit the formation of age spots in the human body by oxidation resistance, has a significant effect on improving the visual fatigue of video display terminal operators, can help eliminate the physical discomfort caused by time difference, has a more significant effect than that of common antioxidants, and has a significant nutritional value as that of astaxanthin and can only be recognized from human foods for health care.
Disclosure of Invention
The invention aims to provide a health food formula containing haematococcus pluvialis astaxanthin, the health food provided by the invention is prepared from natural haematococcus pluvialis fine powder, a white hyacinth bean extract, a henbane seed extract and a jasmine flower extract in a compatibility manner, and tests prove that the health food has obvious antioxidant activity and a health function of improving the immunologic function of a human body.
The invention also aims to provide application of the health food formula containing haematococcus pluvialis astaxanthin in preparing health food, which comprises preparing soft capsules by using the formula.
A health food formula containing haematococcus pluvialis astaxanthin comprises the following components: 36-44% of haematococcus pluvialis fine powder, 25-30% of white hyacinth bean extract, 9-11% of henbane seed extract and 15-30% of jasmine flower extract.
The preparation method of the haematococcus pluvialis fine powder comprises the following steps:
the haematococcus pluvialis fine powder is prepared by taking haematococcus pluvialis as a raw material, extracting for 2-3 times at 30-70 ℃ through 30-65% of ethanol for 40-120min each time, combining extracting solutions of the times, recovering the ethanol, concentrating and then adopting a spray drying method. Wherein the spray drying process is a key process, and the final determination of the optimal production process parameters is as follows: the solid mass fraction of the feeding liquid is 6 percent, the air inlet temperature is 126 ℃, and the flow velocity of hot air is 0.4 m 3/min.
A method for preparing health food formula containing haematococcus pluvialis astaxanthin comprises:
weighing Haematococcus pluvialis fine powder, semen lablab album extract, semen hyoscyami extract and flos Jasmini sambac extract according to a certain proportion, mixing completely, drying at 60-65 deg.C for 1-2 hr, cooling, and sieving with 100 mesh sieve.
The application of health food containing haematococcus pluvialis astaxanthin in preparing health food includes preparing health food preparation directly or combining with other supplementary material.
The method for preparing the health-care product by combining the formula with other auxiliary materials comprises the following steps:
auxiliary materials: beeswax: castor oil: the mass ratio of lecithin is 38:1:1, heating the whole amount of beeswax and half castor oil to 70-80 deg.C to dissolve, adding the rest castor oil and all lecithin under stirring, and cooling to below 45 deg.C to obtain mixed adjuvants.
The raw material medicaments: weighing Haematococcus pluvialis fine powder, semen lablab album extract, semen hyoscyami extract and flos Jasmini sambac extract according to a certain proportion, mixing completely, drying at 60-65 deg.C for 1-2 hr, cooling, and sieving with 100 mesh sieve.
Mixing the mixed raw materials and the mixed auxiliary materials according to the following mixing ratio: mixing the mixed auxiliary materials in a mass ratio of 1:2 to 1:1, homogenizing for 20min, and sieving with a 80-100 mesh sieve to obtain the capsule content.
Mixing gelatin: glycerol: mixing water at a mass ratio of 1: 0.4: 1, heating to 60-65 deg.C to obtain gelatin, vacuumizing to obtain gelatin solution, and making into astaxanthin white hyacinth bean, henbane and jasmine flower soft capsule by using a soft capsule machine.
Compared with the prior art, the invention has the following advantages:
1. the astaxanthin which is an antioxidant active substance in the product is derived from natural haematococcus pluvialis, is prepared by a modern health food preparation method, and has the functions of obvious antioxidation and improvement of human immunity.
2. The raw materials of the product are all from high-quality raw materials which are used as both food and medicine in China, and the product is prepared by the modern preparation process without any chemical additive.
3. The formula takes the astaxanthin as a main raw material and is supplemented with high-quality raw materials which are famous and precious in China and are used as both food and medicines, the formula is reasonable, the advantages are complementary, and the antioxidant function of the astaxanthin is further enhanced;
4. the formula is added with the jasmine flower extract, the castor bean oil and the like, and the jasmine flower extract and the castor bean oil have the antioxidant activity function and also play a role in preventing the astaxanthin from being oxidized and stabilizing the soft capsule.
5. The method for extracting the haematococcus pluvialis fine powder is adopted, so that the main effective component astaxanthin in the haematococcus pluvialis fine powder is reserved to a greater degree.
Detailed Description
The present invention is further illustrated by the following examples, but the present invention is not limited to these examples.
Example 1:
preparation of soft capsules
The unit dose formulation of the soft capsules described in this example consisted of:
120g of haematococcus pluvialis fine powder, 80g of white hyacinth bean extract, 30g of henbane seed extract, 70g of jasmine flower extract, 380g of castor oil, 10g of beeswax and 10g of lecithin.
The preparation method of the soft capsule in the embodiment is as follows:
1. the preparation method of the haematococcus pluvialis fine powder comprises the following steps:
selecting a high-quality haematococcus pluvialis raw material, removing impurities and foreign matters in the haematococcus pluvialis raw material, cleaning the haematococcus pluvialis raw material by using a drum-type medicine washing machine, conveying the cleaned haematococcus pluvialis raw material into a hot air circulation oven, and drying the haematococcus pluvialis raw material at the temperature of 60 ℃ until the moisture content is less than or equal to 10%, so as to obtain the pretreated haematococcus pluvialis raw material. Weighing pretreated Haematococcus pluvialis raw material 200.0 g, extracting with 45% ethanol solution 2.0L at 40 deg.C for 60min, and recovering ethanol extractive solution. Filtering the residue, extracting again according to the above conditions, mixing the two ethanol extractive solutions, and recovering ethanol to obtain concentrated solution. And (3) carrying out spray drying on the concentrated solution, and setting process parameters to be 6% of solid mass fraction of the feed liquid, 126 ℃ of inlet air temperature and 0.4 m3/min of hot air flow rate to obtain the haematococcus pluvialis fine powder. Sterilizing the haematococcus pluvialis fine powder. The sterilization condition is that the irradiation source Co60 and the irradiation dose of 4000 gurry are sterilized for 4 hours for standby. The total astaxanthin content in the haematococcus pluvialis fine powder prepared under the condition is 28.6 mg/g, and the water content of the haematococcus pluvialis fine powder is 2.10%.
2. Mixing and drying materials:
and (3) taking appropriate amount of white hyacinth bean extract, henbane seed extract, jasmine extract and haematococcus pluvialis fine powder which are qualified in inspection, and respectively sieving the white hyacinth bean extract, the henbane seed extract, the jasmine extract and the haematococcus pluvialis fine powder with a 100-mesh sieve. Precisely weighing sieved materials, wherein 120g of haematococcus pluvialis fine powder, 80g of white hyacinth bean extract, 30g of henbane seed extract and 70g of jasmine flower extract. The weighed raw materials are put into a mixer to be mixed for about 15s, and the uniformly mixed raw materials are dried for 2h at 60 ℃ to obtain the mixed raw materials.
3. Preparing the content of the soft capsule:
weighing 380g of castor oil, 10g of beeswax and 5g of lecithin, mixing the beeswax and half of the castor oil, heating to 75 ℃, stirring and adding the lecithin and the rest of castor oil after the beeswax is completely dissolved, and cooling to 40 ℃ to obtain the mixed auxiliary material. Mixing the mixed raw materials and the mixed auxiliary materials, homogenizing in a colloid mill for 20min, and sieving with a 100-mesh sieve to obtain soft capsule contents for later use, wherein the mass ratio of the mixed raw materials to the mixed materials is 1: 1.67.
4. Preparing a finished product of the gelatin melting and soft capsule:
according to the weight percentage of gelatin: glycerol: adding appropriate amount of glycerol, gelatin and purified water into a gelatin dissolving tank at a purified water mass ratio of 1: 0.4: 1, heating to 65 deg.C, vacuumizing to above 0.08 MPa when the gelatin solution in the tank is completely melted, filtering the gelatin solution with filter cloth when the gelatin solution in the tank has no bubbles, and making into gelatin solution. Further preparing the capsule content and the glue solution into soft capsules by a soft capsule machine.
Claims (1)
1. A health food containing haematococcus pluvialis astaxanthin is characterized by comprising the following components: 36-44% of haematococcus pluvialis fine powder, 25-30% of white hyacinth bean extract, 9-11% of henbane seed extract and 15-30% of jasmine flower extract;
the preparation method of the haematococcus pluvialis fine powder comprises the following steps: extracting Haematococcus pluvialis with 30-65% ethanol at 30-70 deg.C for 40-120min for 2-3 times, mixing extractive solutions, recovering ethanol, concentrating, and spray drying to obtain Haematococcus pluvialis fine powder with the spray drying parameters: the mass fraction of solid in the feed liquid is 6 percent, the inlet air temperature is 126 ℃, and the flow rate of hot air is 0.4 m3/min。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811551731.XA CN111329057A (en) | 2018-12-19 | 2018-12-19 | Haematococcus pluvialis astaxanthin health food and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811551731.XA CN111329057A (en) | 2018-12-19 | 2018-12-19 | Haematococcus pluvialis astaxanthin health food and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111329057A true CN111329057A (en) | 2020-06-26 |
Family
ID=71173847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811551731.XA Pending CN111329057A (en) | 2018-12-19 | 2018-12-19 | Haematococcus pluvialis astaxanthin health food and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111329057A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116035183A (en) * | 2023-02-14 | 2023-05-02 | 昆明白鸥微藻技术有限公司 | Antioxidation and color-increasing method for shrimp and crab products |
-
2018
- 2018-12-19 CN CN201811551731.XA patent/CN111329057A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116035183A (en) * | 2023-02-14 | 2023-05-02 | 昆明白鸥微藻技术有限公司 | Antioxidation and color-increasing method for shrimp and crab products |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102283386A (en) | Composite camellia oil health care product with function of reducing blood fat and preparation method thereof | |
| CN105613789A (en) | High-fat and high-dietary-fiber composite animal and plant powdered oil and preparation method and application thereof | |
| CN101313770B (en) | Hemp seed beverage and preparation method thereof | |
| CN102696770A (en) | Walnut vegetable protein drink and method for producing same | |
| CN103651942B (en) | The preparation method of the rare cream of natural plants, plant dilute cream and defatted vegetable protein matter powder | |
| CN102823787B (en) | Gastrointestinal regulation jelly and method for making same | |
| CN110916178A (en) | Radix puerariae enzyme powder and preparation method thereof | |
| CN107441217B (en) | Oral emulsion rich in alpha-linolenic acid and preparation method thereof | |
| CN103859095B (en) | Eight delicacies health preserving tea | |
| CN111329057A (en) | Haematococcus pluvialis astaxanthin health food and preparation method thereof | |
| CN110839881A (en) | Ganoderma lucidum spore oil lycopene soft capsule and preparation process thereof | |
| CN104543274B (en) | A kind of soft sweets containing DHA | |
| KR101739991B1 (en) | Health supplement food comprising donkey bone extracts and manufacturing method for the same | |
| CN105146543A (en) | Krill oil compound preparation for improving immunity and treating three highs | |
| CN102178137B (en) | Indian buead-almond-white paeony root-baical skullcap root health care jelly | |
| CN111264861A (en) | Microcapsule of natural astaxanthin and preparation method thereof | |
| CN101611741B (en) | Preparation method of lead-eliminating milk powder | |
| CN105521178B (en) | A kind of soft capsule with aloe and its preparation method and application | |
| CN106036873A (en) | Hami melon-flavor mint cool wolfberry red date chewable tablet and preparation method thereof | |
| CN107252116A (en) | A kind of complex health care product of relieving mental strain and helping sleep | |
| CN101637481B (en) | Prescription of gingkgo leaf soft capsule and preparation method thereof | |
| CN102640934A (en) | Method for preparing nutritional powder containing alpha-linolenic acid, lecithin, vitamin E, and soluble dietary fiber | |
| CN110679779A (en) | Preparation method of heat-clearing, fire-purging and antiviral red and white koi feed | |
| KR20120118638A (en) | Solid food composition using sturgeon and process of sturgeon capsule by the composition | |
| CN102920750A (en) | Health-care compound preparation for nourishing brain and improving eyesight |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200626 |